ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, offering promising enhancements throughout various health-related and industrial apps. With its structural similarity to Normally derived human serum albumin, OsrHSA presents a safer, more dependable alternative for therapeutic use,